[{"address1": "3300 Bee Cave Road", "address2": "Suite 650-227", "city": "Austin", "state": "TX", "zip": "78746", "country": "United States", "phone": "877-774-4679", "website": "https://www.genprex.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Genprex, Inc., a clinical-stage gene therapy company, focuses on developing gene-based therapies for patients with cancer and diabetes in the United States. The company's lead product candidate is REQORSA (GPX-001), which is in preclinical trials to treat non-small cell lung cancer and small cell lung cancer; and GPX-002, which is in preclinical trials to treat type 1 and type 2 diabetes. Its product pipeline comprises Acclaim-1, which is in phase 2a clinical trial for the treatment of non-small cell lung cancer; Acclaim-2, which is in phase phase 1/2 clinical trial for the treatment of non-small cell lung cancer; and Acclaim-3, which is in phase 1/2 clinical trial for the treatment of small cell lung cancer. The company also develops ONC-001, REQORSA as a monotherapy, which is in phase 1 clinical trial to treat advance non-small cell lung cancer; and ONC-002, REQORSA with Tarceva, which is in phase 2 clinical trial to treat non-small cell lung cancer. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark S. Berger M.D.", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 528157, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan M. Confer M.S.", "age": 41, "title": "President, CEO, CFO & Director", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 606572, "exercisedValue": 0, "unexercisedValue": 79084}, {"maxAge": 1, "name": "Mr. David M. Schloss", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas C. Gallagher Esq.", "title": "Senior Vice President of Intellectual Property & Licensing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Suzanne  Thornton-Jones", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack A. Roth F.A.C.S., M.D.", "title": "Chairman of Scientific & Medical Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.54, "open": 2.6199, "dayLow": 2.49, "dayHigh": 2.6199, "regularMarketPreviousClose": 2.54, "regularMarketOpen": 2.6199, "regularMarketDayLow": 2.49, "regularMarketDayHigh": 2.6199, "beta": -0.534, "forwardPE": -0.95571953, "volume": 23811, "regularMarketVolume": 23811, "averageVolume": 110780, "averageVolume10days": 468640, "averageDailyVolume10Day": 468640, "bid": 2.47, "ask": 2.64, "bidSize": 100, "askSize": 100, "marketCap": 5435633, "fiftyTwoWeekLow": 2.09, "fiftyTwoWeekHigh": 42.0, "fiftyDayAverage": 2.50992, "twoHundredDayAverage": 8.13328, "currency": "USD", "enterpriseValue": -2781487, "floatShares": 2086085, "sharesOutstanding": 2098700, "sharesShort": 39356, "sharesShortPriorMonth": 49674, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0188, "heldPercentInsiders": 0.01672, "heldPercentInstitutions": 0.068179995, "shortRatio": 1.24, "shortPercentOfFloat": 0.019, "bookValue": 4.555, "priceToBook": 0.56860596, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -27626556, "trailingEps": -18.81, "forwardEps": -2.71, "enterpriseToEbitda": 0.1, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "GNPX", "underlyingSymbol": "GNPX", "shortName": "Genprex, Inc.", "longName": "Genprex, Inc.", "firstTradeDateEpochUtc": 1522330200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "d506e914-dc7c-30af-b5b9-638e83c34981", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.59, "targetHighPrice": 320.0, "targetLowPrice": 10.0, "targetMeanPrice": 165.0, "targetMedianPrice": 165.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 8217115, "totalCashPerShare": 3.915, "ebitda": -27794076, "quickRatio": 2.158, "currentRatio": 2.423, "returnOnAssets": -0.96865, "returnOnEquity": -2.02827, "freeCashflow": -13021066, "operatingCashflow": -23104056, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-13"}]